With recent EU regulatory recommendations made around DCTs, here’s everything you need to know. The European Union (EU) recently issued new regulatory recommendations for Decentralized Clinical Trials. This will significantly impact clinical research in the region. The recommendations reflect the EU’s efforts to embrace the latest digital technologies. Improving efficiency and effectiveness of clinical trials …
Five reasons clinical research sites enjoy partnering with Datacubed Health We know that sites play a vital role and hold the key to success in clinical trial research. Finding the right partner can make a significant impact outcomes. Datacubed Health is the leading provider of patient engagement solutions for the clinical trial industry. We deliver …
Clinical trials for rare diseases face unique challenges, such as small patient populations and limited access to treatment options. With this in mind, behavioral science principles and technological advancements can help improve outcomes in rare disease clinical trials. Here are five ways behavioral science and technology can help: Enhance patient engagement with behavioral science principles …
Cell and gene therapy have been among the most promising medical technologies in recent years. As well as the potential to revolutionize the treatment of many diseases. However, the success of clinical trials for these therapies can be affected by a number of factors. These factors include patient recruitment and retention, adherence to treatment protocols, …
A Hybrid Clinical Trial is a type of medical research study that includes elements of traditional face-to-face clinical trials and virtual or remote elements delivered over the internet or via a mobile device. This type of trial allows for a more flexible approach to conducting clinical research, which can have many benefits. Benefits of a …
Medication adherence is a critical aspect of clinical trials. It can significantly impact the trial’s outcome and the ability to draw accurate conclusions from the data. Adherence refers to the extent to which a patient follows the prescribed treatment regimen, including taking medication, keeping appointments, and following other recommended therapies. For a clinical study to …
With dropout rates soaring and recruitment rates declining, Sponsors and CROs can’t afford to take any chances regarding their consenting and onboarding processes. A study conducted in 2018 showed that the general overall perception of clinical trials is that they are burdensome. The study surveyed over 12,000 individuals representing 68 countries and included over 2,000 …
Translation services have long been one of the most burdensome pain points of a clinical study. Learn how we’re alleviating this pain through our revolutionary approach to eCOA/ePRO and translation processes.
Read moreHow our eCOA/ePRO platform is reducing the pain of translations
We operate with the mission to advance access to healthcare for everyone, everywhere. That’s our why. What’s yours? Discover a new way to improve the clinical trial experience.
Read moreInnovations in ePRO/eCOA and Patient Engagement: What’s Your ‘Why’?
We’re transforming the clinical trial experience for all stakeholders: sponsors, CROs, sites, and patients. By leveraging technological innovation infused with behavioral science principles we have developed a state-of-the-art platform designed to deliver better retention, compliance, and overall clinical trial experience.
Read moreWhat’s the point of innovation? For us, it’s a better patient experience.